Inventiva

42 articles with Inventiva

• Inventiva Reports First-Half of 2021 Financial Information

  7/28/2021

  Inventiva, a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, mucopolysaccharidoses and other diseases with significant unmet medical need, reported its cash position as of June 30, 2021 and its revenues for the first half of 20211.

• 

  BioSpace Global Roundup: Ayala Moves Forward with Desmoid Tumor Asset in Phase II/III Study

  1/7/2021

  Biopharma and life sciences companies from across the globe provide updates on their pipelines and business.
• 

  BioSpace Global Roundup, Nov. 12

  11/12/2020

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
• 

  FDA Awards Fast Track Designation to Multiple Non-COVID-19 Candidates

  11/4/2020

  While the world has largely been focused on the development of vaccines and therapeutics for COVID-19, the U.S. FDA has remained busy lining up potential approvals of medications for other diseases and illnesses.
• 

  BioSpace Global Roundup, Oct. 15

  10/15/2020

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
• 

  In Tough Market, Inventiva's NASH Drug Receives Breakthrough Therapy Tag

  10/13/2020

  NASH is a metabolic disease similar to cirrhosis of the liver, but occurs in people who drink little, if any, alcoholic.
• 

  BioSpace Global Roundup, May 28

  5/28/2020

  Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
• 

  BioSpace Global Roundup, May 21

  5/21/2020

  Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations.
• 

  BioSpace Global Roundup, April 9

  4/9/2020

  Biopharma companies from across the globe provide updates to their business operations and pipelines.
• 

  BioSpace Global Roundup, Dec. 5

  12/5/2019

  Companies from across the globe provide updates on their business and pipelines.
• 

  BioSpace Global Roundup, Oct. 3

  10/3/2019

  Companies from across the globe share information on their business and pipelines.
• 

  BioSpace Global Roundup, Sept. 26

  9/26/2019

  Companies from across the globe share updates on their business and pipelines.
• 

  BioSpace Global Roundup, Sept. 12

  9/12/2019

  Companies and organizations from across Europe, Asia and North America share updates on their business and pipelines.
• 

  BioSpace Global Roundup, Sept. 5

  9/5/2019

  Companies from across Europe and Asia share updates on their business and pipelines.
• 

  BioSpace Global Roundup, Aug. 29

  8/29/2019

  Companies from across the globe provide updates on their business and pipelines.
• 

  BioSpace Global Roundup, Aug. 22

  8/22/2019

  Companies from across the globe provide updates on their business and pipelines.
• 

  BioSpace Global Roundup, June 13

  6/13/2019

  Companies from across the globe share business and pipeline updates.
• 

  BioSpace's Global Biopharma Roundup: April 25

  4/25/2019

  Companies across Europe and Asia provide information about deal, clinical trials and more, with news from Synaptive Medical, Epic, Inventiva, Velabs, and more.
• 

  Inventiva Discontinues Systemic Sclerosis Drug After Mid-Stage Flop

  2/19/2019

  Shares of France-based Inventiva have plunged more than 45 percent after the company reported that its experimental treatment for a rare autoimmune disease failed to hit primary and secondary endpoints in a mid-stage trial.

• Inventiva to Present at Two Upcoming Investor Conferences

  11/13/2017

  Inventiva today announced that Frédéric Cren, CEO of Inventiva, will present at two upcoming investor conferences.